Literature DB >> 18774681

The management of thoracic outlet syndrome in teenaged patients.

David A Rigberg1, Hugh Gelabert.   

Abstract

While thoracic outlet syndrome (TOS) is known to afflict teenaged patients, reported data are limited to small groups or individual cases. Management of TOS in teenagers presents many issues, including performing surgery in patients whose skeletal growth may not be completed. Additionally, surgical intervention may result in loss of school time. The aim of this study was to assess our results with a large series of young TOS patients in order to provide insight toward achieving optimal care. Via a retrospective chart review, we identified all patients <20 years of age undergoing first rib resection for TOS during an 11-year period (August 1994-September 2005) at a single university hospital. History, indication, operative details, and pertinent follow-up were obtained from the records. There were 18 patients <20 who underwent first rib resection in the study period (all but one via a transaxillary approach). Ages ranged 13-19 years. Twelve patients had disabling neurogenic (NG) TOS, and six presented with Paget-Schroetter syndrome (PS). Seventy-two percent of patients were female. Most students (14/18) were forced to take a leave from school due to severity of symptoms. Eighty-five percent of female patients presented with NG TOS, whereas PS TOS affected 80% of male patients. All PS TOS patients were involved in high-intensity athletics, while 75% of NG TOS patients were student athletes. Follow-up ranged from 30 days to over 12 years. There were no significant operative complications in either group. Forty-two percent of NG patients experienced continued symptoms leading to anterior scalenectomy. All PS patients had successful lysis of their thrombotic processes. Overall, 25% of NG TOS patients also required postoperative trigger point injections. All patients eventually recovered and were able to resume academic as well as competitive athletic activities. TOS can be effectively and safely treated in the teenage years. PS responds well to standard thrombolysis and surgical decompression. NG TOS presenting in these young patients appears more likely to require extensive surgical decompression (both rib resection and total scalenectomy) in order to achieve optimal results. Given the psychosocial and academic implications of this disease, careful diagnosis and appropriate treatment are imperative.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774681     DOI: 10.1016/j.avsg.2008.04.017

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  5 in total

Review 1.  How We Manage Pediatric Deep Venous Thrombosis.

Authors:  Marisol Betensky; Mark A Bittles; Paul Colombani; Neil A Goldenberg
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

2.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Simultaneous bilateral magnetic resonance angiography to evaluate thoracic outlet syndrome.

Authors:  Dario Poretti; Ezio Lanza; Luca Maria Sconfienza; Giovanni Mauri; Vittorio Pedicini; Luca Balzarini; Francesco Sardanelli
Journal:  Radiol Med       Date:  2014-10-28       Impact factor: 3.469

4.  Thoracic outlet syndrome: a controversial clinical condition. Part 1: anatomy, and clinical examination/diagnosis.

Authors:  Troy L Hooper; Jeff Denton; Michael K McGalliard; Jean-Michel Brismée; Phillip S Sizer
Journal:  J Man Manip Ther       Date:  2010-06

5.  Treatment-Related Outcomes in Paget-Schroetter Syndrome-A Cross-Sectional Investigation.

Authors:  Riten Kumar; Katherine Harsh; Surbhi Saini; Sarah H O'Brien; Joseph Stanek; Patrick Warren; Jean Giver; Michael R Go; Bryce A Kerlin
Journal:  J Pediatr       Date:  2018-12-07       Impact factor: 4.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.